BioAge Labs, Inc. (BIOA)

BioAge Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	159.09	24.96	27.64
Cash & Cash Equivalents	159.09	24.96	27.64
Cash Growth	-	-9.72%	-
Other Current Assets	4.57	0.35	0.39
Total Current Assets	163.65	25.31	28.03
Property, Plant & Equipment	-	0.32	0.32
Long-Term Investments	-	0.1	-
Goodwill and Intangibles	-	0.2	0.05
Other Long-Term Assets	-	0	0.03
Total Long-Term Assets	-	0.62	0.4
Total Assets	-	25.92	28.43
Accounts Payable	-	1.87	2.26
Current Debt	-	45.05	0.22
Other Current Liabilities	12.98	11.25	3.38
Total Current Liabilities	12.98	58.17	5.86
Long-Term Debt	-	8.2	2.25
Other Long-Term Liabilities	-	0.23	0.15
Total Long-Term Liabilities	-	8.43	2.41
Total Liabilities	-	66.6	8.27
Total Debt	11.71	53.25	2.47
Debt Growth	-	2057.70%	-
Retained Earnings	-	-181.7	-117.85
Comprehensive Income	-	0.16	0.17
Shareholders' Equity	-197.13	-173.4	-112.56
Net Cash / Debt	147.37	-28.3	25.18
Working Capital	150.67	-32.86	22.17

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).